Skip to content
Abierto
Menu

Justification

Justification and Approval for Sole Source TPOXX Requirement

JA-24-Edg-632

Department of the Army, W6QK ACC-APG. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Siga Technologies, Inc.

$8,999,677.03 obligated so far on USAspending, August 2, 2024, contract W911SR-24-C-0030

Description

As published on SAM.gov.

The purpose of this other than full and open competition contract to Siga Technologies Inc., is to procure additional doses of oral TPOXX treatment courses and IV treatment courses to maintain the national stockpile of smallpox therapeutics. Both TPOXX treatment courses have been approved by the United States Food and Drug Administration.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Siga Technologies, Inc.
UEI
VJRNRTSL22K4
CAGE
1V4X4
Vendor location
New York, NY
Contract
W911SR24C0030, definitive contract
Obligated
$8,999,677.03
Actions
2 between August 2, 2024 and October 17, 2024
Competition
Not Competed, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Procurement of 23,030 Tpoxx Oral Courses and 50 Tpoxx IV Courses. to Maintain National Stockpile.
Match
award number W911SR24C0030 equals the contract number; same awarding office W911SR (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 5, 2024

    Justification

    SAM.gov, notice 691e2e5896da4b20a1bfb77bf791e086

Points of contact

Also open from this buyer